Search Results

ATOVIB GOLD 10

ATORVASTATIN 10mg. IP + CLOPIDOGREL 75mg. IP + ASPIRIN 75mg. IP

Send Enquiry

CURE

Capsules

Packaging and packing Type

Alu Strip | 10x15

MRP :

₹108.5

PTR :

₹77.5

PTS :

₹69.75

A combination drug of blood-thinning agents and cholesterol-lowering agents for atherosclerotic patients suffering from various heart diseases. (Mahmo... Read More

Composition

ATORVASTATIN 10mg. IP + CLOPIDOGREL 75mg. IP + ASPIRIN 75mg. IP

Send Enquiry

India’s Largest Pharma Franchise

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

Description

A combination drug of blood-thinning agents and cholesterol-lowering agents for atherosclerotic patients suffering from various heart diseases. (Mahmoud Mohamed Issa, 2013) Works by preventing platelets from forming clots that may cause a heart attack or stroke. Blocks the platelet adenosine diphosphate receptor, and powerfully inhibits platelet activation, degranulation, and aggregation. (Jehangir N Din, 2005) A powerful compound that has the ability to reduce cardiovascular disease by stopping the growth of plaques in artery walls. (Ursula Gresser, 2004) Demonstrates considerable success at reducing thrombotic complications of acute coronary syndrome and percutaneous coronary intervention. (Abu-Fadel, 2009) Significantly reduces total cholesterol, triglyceride, and low-density lipoprotein cholesterol in hypercholesterolemia patients. (Chumpol Piamsomboon 1, 2002) Prevents cardiovascular events in patients at higher risk of cardiovascular disease, as well as in those with acute coronary syndrome. (Christopher W. Walker, 2007) Exerts antiplatelet effects by inhibiting thromboxane A2 production and adenosine diphosphate-induced platelet aggregation pathways. (Hani Jneid, 2003) Reduces the risk of recurrent cardiovascular events in various subgroups of patients with vascular disease. (J Floris S Logman, 2010) Decreases levels of total cholesterol, low-density lipoprotein (LDL)-cholesterol, triglyceride, and very low-density lipoprotein (VLDL)-cholesterol and increases high-density lipoprotein (HDL)-cholesterol in patients with a wide variety of dyslipidaemias. (H S Malhotra, 2001) Offers additional benefits for those patients at high risk and those with established cardiovascular disease. (T T Keller, 2007)

Side Effects

Abdominal pain, Nosebleeds, Diarrhea, Headache, Muscle pain

Indication

Heart attack , Stroke , Heart-related chest pain (angina) , Hyperlipidemia

Important Notice

Temp data

Storage Condition

Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Franchise Enquiry

Request a callback to get more information about becoming a PCD Franchise Owner***

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner